Promising Shorter and More Effective Treatment Regimens for Drug-Resistant Tuberculosis: Recent Research Found

Journal of Lung, Pulmonary & Respiratory Research
doi 10.15406/jlprr.2018.05.00163
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC

Related search

Shorter Regimens for Multidrug-Resistant Tuberculosis Should Also Be Applicable in Europe

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Potential Drug–drug Interactions Between Antiretroviral Therapy and Treatment Regimens for Multi-Drug Resistant Tuberculosis: Implications for HIV Care of MDR-TB Co-Infected Individuals

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Final Treatment Outcomes of Multidrug- And Extensively Drug-Resistant Tuberculosis Patients in Latvia Receiving Delamanid-Containing Regimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Treatment Outcomes of Regimens Containing Delamanid Within Therapy of Multiple and Extensive Drug Resistant Tuberculosis in the Russian Federation

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2019English

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium Tuberculosis

Science
MultidisciplinaryPhilosophy of ScienceHistory
2009English

Drug-Resistant Tuberculosis

Drug and Therapeutics Bulletin
MedicinePharmacology
1995English

Decentralized, Community-Based Treatment for Drug-Resistant Tuberculosis: Bangladesh Program Experience

Global health, science and practice
Health PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy